|
FDA Expands Use of Tykerb
The approval was based on a study that showed that patients on a combination of the drugs went 35 weeks before a cancer progression compared to 13 weeks for women who got Femara alone.
More... |
| All times are GMT -7. The time now is 11:07 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021